Best Pharma and BioTech News Podcasts (2024)

1
Scrip's Five Must-Know Things - 10 June 2024 15:38

2h ago15:38

15:38

Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 June 2024. In this episode: BIO Notebook; ASCO roundup; data on Carvykti in community at ASCO; strong new results for tirzepatide in MASH; and orphan slowdown signals new path ahead.https://scrip.citeline.com/SC150401/Quick-Listen-Scrips-Five-MustKnow-Thi…

1
The Generics Bulletin Podcast: Teva, Sandoz, Sawai and US Orange Book patents 24:18

5h ago24:18

24:18

Generics Bulletin's editorial team discusses the latest strategic developments for major industry players Teva, Sandoz and Sawai, as well as explaining the recent debate over US patent listings in the FDA's Orange Book.By Citeline

1
A look at the top 10 pharma drug ad spenders 9:35

6h ago9:35

9:35

The Fierce Pharma Marketing team publishes a special report each year on the top pharmaceutical drug ad spenders. This year’s report, which includes numbers for 2023, was published on Monday. AbbVie was the standout in this edition, having spent heavily on ads for Skyrizi and Rinvoq. Overall spending on the top 10 ads also experienced a sizable inc…

1
Targeting AML with a New Generation of T-Cell Therapies, ft. Brian Atwood, Chairman and CEO of CERo Therapeutics 29:39

2d ago29:39

29:39

In this episode, Ayesha spoke with Brian Atwood, Chairman and CEO of CERo Therapeutics, a company pioneering a new generation of autologous T-cell-based therapies for both hematologic and solid tumor cancers. Prior to joining CERo, Brian Atwood served as Chairman of the board of directors of Phoenix Biotech Acquisition Corp., which merged with CERo…

1
China Biotech Podcast - 5 June 2024 (Chinese language) 23:09

3d ago23:09

23:09

Guest speaker Guangzuo Luo, chief scientific officer of Bioncetech, joins China-based editors Brian Yang and Dexter Yan in this episode, which looks at Chinese biotechs going global, and the opportunities and challenges in the latest industry latest trends.https://scrip.citeline.com/SC150370/China-Biotech-Podcast-Going-Global-Trends-Rare-Disease-Dr…

1
JB CEO On CDMO Growth, Red Sea Crisis And More 34:06

4d ago34:06

34:06

In an interview with Scrip, JB CEO Nikhil Chopra addresses rumours of a sale of a stake in the Indian pharma/CDMO company by private equity fund KKR, recent acquisitions, including from Novartis, as well as JB's ambitions to ramp up the cardiology segment and its CDMO business, which already has major clients including J&J.https://scrip.citeline.co…

1
Scrip's Five Must-Know Things - 3 June 2024 15:09

5d ago15:09

15:09

Audio roundup of selected biopharma industry content from Scrip over the business week ended 31 May 2024. In this episode: ASCO preview; Asahi’s US acquisition; Novartis aims for renal disease dominance; paying for gene therapies; and US BIOSECURE Act diluted.https://scrip.citeline.com/SC150361/Quick-Listen-Scrips-Five-MustKnow-ThingsPlaylist: http…

1
Pharma and Biotech Daily: Your Daily Dose of Healthcare Insights 4:21

5d ago4:21

4:21

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.## The healthcare industry is facing various challenges, including nursing homes suing to block a staffing mandate, healthcare organizations not being prepared for cyberattacks, the impact of Ascension's cyberattack, and a …

1
The Scrip Awards Podcast. Episode 1: Genmab: The Ongoing Evolution Of Europe’s Antibody Powerhouse 22:15

7d ago22:15

22:15

An interview with Genmab’s Jan van de Winkel to mark 25 years of the company, and 20 years of the Scrip Awards. A brief history of the antibody-focused biotech company so far, and its plans for future expansion.By Citeline

1
How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone 50:18

7d ago50:18

50:18

In this episode we unpack the Corporate Sustainability Reporting Directive (CSRD) with the help of ESG expert Jasper Crone, drilling down into exactly what consumer healthcare companies need to know about this enormously complex and significant piece of EU legislation.3:30 Introduction to the CSRD7:45 What companies are affected by the CSRD15:00 Sp…

1
A cell therapy reckoning 6:31

7d ago6:31

6:31

The Fierce Biotech team published a four-part series this week exploring cell therapy, a modality that has faced clinical challenges, manufacturing constraints and multiple practice-changing events. In today’s episode, Fierce’s Annalee Armstrong and Gabrielle Masson discuss the series of special reports and key insights from their interviews with m…

1
Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions 37:01

8d ago37:01

37:01

Advancing Investigational New Drugs (INDs) can be a complex process, especially for smaller companies. Listen to your free podcast now as Marcus Delatte, PhD, Vice President at Allucent and Harshini Neelakantan, Executive Director at Ridgeline Therapeutics discuss best practices and considerations for leveraging your pre-IND meeting and submitting …

1
'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovation 35:52

9d ago35:52

35:52

Astellas Pharma’s chief commercial officer, Claus Zieler, discusses the biopharma industry’s responsibility to drive change in health care.By Citeline

1
Exploring Next-Gen Antivirals ft. Sam Lee, PhD, Co-CEO & President, Cocrystal Pharma 24:45

9d ago24:45

24:45

In this episode, Ayesha spoke with Sam Lee, PhD, Co-Chief Executive Officer and President of Cocrystal Pharma, a company developing novel antiviral therapeutics against COVID-19 and other coronaviruses, influenza viruses and noroviruses. Cocrystal Pharma leverages a unique structure-based drug discovery platform, complemented by Nobel Prize-winning…

1
China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen 45:35

11d ago45:35

45:35

NeuShen CEO Joan Shen discusses with Brian Yang about developing CNS drugs in China, the venture's business rationale, challenges and fundraising. She also discusses two leading assets for schizophrenia and epilepsy in first-in-human studies, as well as a gene therapy collaboration for ALS with UMass's Gao Lab.https://scrip.citeline.com/SC150328/Ch…

1
Citeline Japan Awards 2024 - Enter Now! (Bilingual English/Japanese) 5:16

11d ago5:16

5:16

As the 15 July entry deadline for the 3rd edition of the annual Citeline Japan Awards approaches, join us in this bilingual English/Japanese podcast to learn more about the categories and event itself. (Japanese starts at 2' 25".)English event site: https://www.citeline.com/en/awards/citelinejapanawardsJapanese event site: https://www.citeline.com/…

1
Scrip's Five Must-Know Things - 27 May 2024 16:00

12d ago16:00

16:00

Audio roundup of selected biopharma industry content from Scrip over the business week ended 24 May 2024. In this episode: Biogen’s immunology acquisition; AstraZeneca looks to cement respiratory lead; why US FTC is tough on pharma; the US election’s impact on pharma; and how new AI tools are impacting medical affairs.https://scrip.citeline.com/SC1…

1
Drug Fix: Novel Clinical Trial Reg Problems, NIH Drug ‘Access Plans’, Good Ole Days Of Woodcock 23:09

14d ago23:09

23:09

Pink Sheet editors discuss the US FDA’s consideration of regulatory changes to promote innovative clinical trial designs (:32), an NIH proposal to require patent licensees create plans to ensure access to the commercialized product (7:29), and lawmakers longing for the days when Janet Woodcock ran the FDA’s Center for Drug Evaluation and Research (…

1
Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturing (Part III) 39:37

14d ago39:37

39:37

This week’s episode of “The Top Line,” is the final part of a three-part series diving into the latest advancements in cell and gene therapy manufacturing. In this episode, Fierce Pharma’s Fraiser Kansteiner is joined by Bruce Levine, Ph.D., who is the co-inventor of Kymriah and the Barbara and Edward Netter Professor in Cancer Gene Therapy at the …

1
【3分で解説世界のファーマ】第18回 GLP-1を超える肥満治療薬のカギとは？(Japanese-language podcast) 3:31

19d ago3:31

3:31

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「Hibernating Squirrels And Exercise In A Pill: The Next Wave of Cardiometabolic Therapies（邦題意訳：GLP-1を超える心代謝系治療薬のヒントは、冬眠するリスか、地道な運動か）」（日本語版）https://www.citeline.com/ja-jp/resources/hibernating-squirrels-and-exercise-in-a-pill※全文の閲覧には情…

1
[Sponsored] Opportunities & Challenges of Digital Pathology Adoption in CDx Development 17:00

16d ago17:00

17:00

In the fast-paced field of life sciences, digital pathology is poised to be a game-changer. In this episode, we sit down with Grace Lee and Douglas Clark of Agilent Technologies to explore the opportunities and challenges associated with companion diagnostics (CDx). Clark kicks off, shedding light on the current levels of digital pathology adoption…

1
Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing 25:21

16d ago25:21

25:21

In this episode of the In Vivo podcast, Hakim Yadi, CEO and co-founder of UK techbio company Closed Loop Medicine, discusses how his company is pairing software and predictive analytics with medications old and new to tailor drug dosing to each patient.By Citeline

1
Gene Editing Innovations with Programmable Gene Insertion (PGI) Technology ft. Dr. John Finn, Tome Biosciences 33:39

16d ago33:39

33:39

In this episode, Ayesha spoke with John Finn, PhD, Chief Scientific Officer at Tome Biosciences, a company developing programmable gene insertion (PGI) technology. PGI is a cutting-edge gene editing technology that allows for the insertion of large sequences of DNA with site-specific precision. PGI is a revolutionary approach for the development of…

1
Leading PRO Discusses Plans For Administering State EPR Programs 36:59

17d ago36:59

36:59

In this episode, HBW chats with John Hite of the leading producer responsibility organization administering three Extended Producer Responsibility laws launching next year. With a 1 July deadline to register for his PRO, Circular Action Alliance, Hite discusses steps companies should take now, how his organization will assist producers and expectat…

1
개발 VS 딜메이킹: 블록버스터 신약을 확보하는 방법 (Korean-language podcast) 3:24

18d ago3:24

3:24

빅파마 기업들의 블록버스터 신약 확보 전략에 대한 Scrip 기사를 요약한 내용입니다.https://scrip.citeline.com/SC150256/Development-Versus-Dealmaking-How-To-Obtain-A-BlockbusterPlaylist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniBy Citeline

1
How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane 32:07

18d ago32:07

32:07

In this episode, HBW Insight catches up with Albert Swane, founder and CEO of Dutch consumer healthcare firm, TheOTCLab, to talk about business strategy. Having grown the company with widely successful European OTC medical devices like Dr. Yglo, FungeX and Kidsner, Swane is perfectly placed to explain how to create and grow OTC brands. Swane also o…

1
[Sponsored] Unlocking health equity: The promise of digital health technologies 15:11

22d ago15:11

15:11

What is the transformative potential of digital health technologies in advancing health equity? Rabin Martin, a global health consulting firm, explores those possibilities in this engaging episode. The conversation highlights the excitement surrounding digital tools and advanced analytics in achieving deeper insights, consistent care delivery, work…

1
Scrip's Five Must-Know Things - 20 May 2024 16:55

19d ago16:55

16:55

Audio roundup of selected biopharma industry content from Scrip over the business week ended 17 May 2024. In this episode: the life of a blockbuster; blockbusters by indication; gene therapy struggles; sun shines on AstraZeneca and GSK; and Korean ventures look to Japan.https://scrip.citeline.com/SC150281/Quick-Listen-Scrips-Five-MustKnow-ThingsPla…

1
Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation 38:55

21d ago38:55

38:55

Pink Sheet editors and reporter consider the implications of the BIOSECURE Act as it advances through a House committee (:30), whether industry would improve clinical trial diversity with tougher enforcement of the regulation (22:26), as some have suggested, and the FDA’s use of platform technology ideas for gene therapies not participating in the …

1
Advancements in cell & gene therapy manufacturing (Part II) 31:23

25d ago31:23

31:23

This week’s episode of “The Top Line” is the second part of a three-part series exploring the latest advancements in cell and gene therapy manufacturing. In this episode, Fierce Pharma’s Fraiser Kansteiner interviews Delara Motlagh, head of cell therapy at Catalent; Becky Butler Cap, senior vice president of biotherapies at Vitalant; and Kevin Kyle…

1
May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma 16:04

22d ago16:04

16:04

Flora gives an overview of the budding landscape of neoadjuvant therapy in melanoma and provides insight on the nuances of this market.Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZX…

1
New Frontiers in Epilepsy and Seizure Treatments ft. Dr. Jeremy Levin and Meg Alexander, Ovid Therapeutics 47:51

23d ago47:51

47:51

In this episode, Ayesha spoke with Jeremy Levin, D. Phil, MB BChir, CEO and Chairman of Ovid Therapeutics Inc., and Meg Alexander, Chief Strategy Officer at Ovid. Ovid Therapeutics is a biopharmaceutical company focused on the development of medicines for epilepsies and seizure-related neurological disorders. Prior to founding Ovid, Dr. Levin was p…

1
China Biotech Podcast - 15 May 2024 (Chinese- and English-Language) 35:28

24d ago35:28

35:28

In this bilingual Chinese- and English-language edition, China-based editors Brian Yang and Dexter Yan, along with guest speaker Derrick Gingery from the Pink Sheet in the US, discuss the planned US BIOSECURE Act and markup vote. Brian and Dexter also look at recent R&D updates from Chinese biopharma firms on their antibody-drug conjugate pipelines…

1
Episode 62: Josh Mandel-Brehm - CEO, CAMP4 Therapeutics 20:10

24d ago20:10

20:10

Explore the untapped potential of RNA amplifying therapeutics with the CEO of CAMP4 Therapeutics, Josh Mandel-Brehm. We uncover the power of antisense oligonucleotides in rewriting the narrative for genetic diseases characterized by protein deficiency. Josh takes us behind the scenes of their innovative RNA Actuating Platform (RAP), a map charting …

1
Scrip's Five Must-Know Things - 13 May 2024 14:29

26d ago14:29

14:29

Audio roundup of selected biopharma industry content from Scrip over the business week ended 10 May 2024. In this episode: AstraZeneca’s Vaxzevria farewell; the next wave of cardiometabolics; Pfizer recruits prominent analyst: foundation pleas for China rare disease therapies; and Gossamer partners up for respiratory therapy.https://scrip.citeline.…

1
Fulfilling the promise of cell & gene therapies through manufacturing (Part I) 29:15

1M ago29:15

29:15

This week’s episode of “The Top Line,” kicks off a series diving into the latest advancements in cell and gene therapy manufacturing. In this episode, Fierce Pharma’s Fraiser Kansteiner sits down with Ori Biotech CEO Jason Foster and the Cell Therapy Manufacturing Center's CEO, Jason Bock. They delve into the current state of cell and gene therapy …

1
Episode 15: Digital Trust 20:20

29d ago20:20

20:20

In this episode, Medtech Insight senior reporter Hannah Daniel speaks to Mark Brown, Global Managing Director of Digital Trust Consulting at the British Standards Institute about digital trust. In a world of cybersecurity breaches and ransomware attacks on hospitals, digital trust between companies and consumers is key, but current siloed operation…

1
#31 - Dynamics of Venture Debt: Balancing Legal and Business Objectives | David Ephraim 26:57

29d ago26:57

26:57

Navigating the intricate world of venture debt requires a deep understanding of both the legal landscape and financial imperatives. David Ephraim from Morrison & Foerster brings over two decades of experience to the table, making him a leading authority on structuring deals that align legal precision with business innovation. This episode, hosted b…

1
The State of Infectious Diseases and New Trivalent Flu Vaccine ft. Infectious Disease Experts Dr. William Schaffner and Dr. Kelly Moore 48:51

1M ago48:51

48:51

In this episode, Ayesha spoke with William Schaffner, MD, Professor of Preventive Medicine Health Policy and Professor in the Division of Infectious Diseases at Vanderbilt University; and Kelly Moore, MD, MPH, President and CEO at Immunize.org and Associate Professor of Health Policy at Vanderbilt University. Dr. Schaffner and Dr. Moore discussed t…

1
Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta 29:28

1M ago29:28

29:28

In this episode, HBW Insight chats with sustainable packaging expert Tony Perrotta about why it’s so difficult to replace plastic pill packs in medicines packaging. Perrotta works for PA Consulting, which set up the Blister Pack Collective alongside consumer healthcare partners Haleon, Bayer and Sanofi. They are working with PulPac, which has inven…

1
Episode 61: William Korinek - CEO and Co-Founder, Astrocyte Pharmaceuticals 24:20

1M ago24:20

24:20

Embark on a journey through the neurons and synapses of brain science with William Korinek, the CEO of Astrocyte Pharmaceuticals. In a conversation that fuses the molecular intricacies of neuroprotection with the humanistic pursuit of medical advancement, Bill reveals his unique path from molecular biologist to biotech innovator. Together, we unrav…

1
Scrip's Five Must-Know Things - 7 May 2024 15:01

1M ago15:01

15:01

Audio roundup of selected biopharma industry content from Scrip over the business week ended 3 May 2024. In this episode: Japan’s Ono buys US oncology firm; strong growth but supply issues for Lilly; Novo and Lilly make their money work; BMS cuts jobs, costs; and Big Pharma’s support for bioventures.https://scrip.citeline.com/SC150211/Quick-Listen-…

1
Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review 31:23

1M ago31:23

31:23

Pink Sheet reporter and editors discuss what an upcoming listening session means for the FDA’s advisory committee reform effort (:32), the agency’s efforts to help the clinical trial modeling and simulation industry (16:22), and the UK’s MHRA plan to use artificial intelligence to assist in drug application reviews (21:05).More On These Topics From…

1
A closer look at 2023's top biopharma deals and what lies ahead 18:07

1M ago18:07

18:07

This week on "The Top Line," we're diving into the details of the spree of big-money biopharma deals in 2023 and examining what that means for this year. Fierce Pharma Senior Writer Kevin Dunleavy sits down with Cody Powers, a consultant who advises companies on business development and franchise growth strategy, to discuss the reasons behind the n…

1
Psychedelic-Based Therapeutics for Generalized Anxiety Disorder (GAD) – Interview with Robert Barrow, CEO, MindMed 26:04

1M ago26:04

26:04

In this episode, Ayesha spoke with Robert Barrow, CEO and Board Director at MindMed, a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. The company is developing innovative psychedelic-based product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways…

1
Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch 6:35

1M ago6:35

6:35

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights key interviews with Philips’ CEO Roy Jakobs on NAM’s draft framework on AI, BD’s CTO Beth McCombs R&D initiatives and HSS spine co-chair Sheeraz Qureshi on his vision for integrating AI tech. Hannah Daniel discusses the FDA’s new initiative to create an idea lab for me…

1
April Datamonitor Podcast 2024: AAN coverage 51:54

1M ago51:54

51:54

Flora and Emma are joined by Datamonitor’s CNS analysts Summer, Joseph, and Wen-Yu to discuss coverage from AAN.Other platforms (in addition to SoundCloud):Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vy…

1
Scrip's Five Must-Know Things - 30 April 2024 14:15

1M ago14:15

14:15

Audio roundup of selected biopharma industry content from Scrip over the business week ended 26 April 2024. In this episode: 2023’s top selling drugs and the COVID cliff; falling sales force Roche to reassess priorities; Phase III immunology win for Sanofi; BMS’s strong pipeline: and which companies could be acquired next.https://scrip.citeline.com…

1
2024 Global Generics & Biosimilars Awards 4:30

1M ago4:30

4:30

2024 Global Generics & Biosimilars Awards by CitelineBy Citeline

1
Podcast: Facilitating Patient Monitoring in CAR-T Development 19:28

1M ago19:28

19:28

Learn how molecular technology is enhancing patient safety for CAR-T clinical trials. US FDA recently initiated class safety labeling changes after evaluating the safety of CAR-T cancer treatment therapies. What does this mean for developers in the CAR-T landscape? Listen to your free podcast to find out.Listen in on the conversation as experts fro…

Podcasts Worth a Listen

Pharma And BioTech News Podcasts

Podcasts Worth a Listen

Quick Reference Guide